{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:20:19Z","timestamp":1790014819587,"version":"4.0.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,6,4]],"date-time":"2014-06-04T00:00:00Z","timestamp":1401840000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Physical and Rehabilitation Medicine"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.rehab.2014.05.004","type":"journal-article","created":{"date-parts":[[2014,6,5]],"date-time":"2014-06-05T10:20:26Z","timestamp":1401963626000},"page":"302-314","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["OnabotulinumtoxinA and multiple sclerosis"],"prefix":"10.1016","volume":"57","author":[{"given":"B.","family":"Schurch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Carda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rehab.2014.05.004_bib0005","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1177\/1352458506075651","article-title":"The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines","volume":"13","author":"de Seze","year":"2007","journal-title":"Mult Scler"},{"key":"10.1016\/j.rehab.2014.05.004_bib0010","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1212\/01.wnl.0000264416.53077.8b","article-title":"Disparities in the management of multiple sclerosis-related bladder symptoms","volume":"68","author":"Marrie","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.rehab.2014.05.004_bib0015","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/(SICI)1520-6777(1998)17:2<89::AID-NAU2>3.0.CO;2-8","article-title":"Urological dysfunctions and upper urinary tract involvement in multiple sclerosis patients","volume":"17","author":"Giannantoni","year":"1998","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.rehab.2014.05.004_bib0020","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1097\/01.ju.0000049644.27713.c8","article-title":"Relationship of bladder dysfunction to lesion site in multiple sclerosis","volume":"169","author":"Araki","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.rehab.2014.05.004_bib0025","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0094-0143(05)70326-8","article-title":"Urodynamics and multiple sclerosis","volume":"23","author":"Hinson","year":"1996","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.rehab.2014.05.004_bib0030","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1136\/jnnp.2008.159178","article-title":"A UK consensus on the management of the bladder in multiple sclerosis","volume":"85","author":"Fowler","year":"2009","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.rehab.2014.05.004_bib0035","first-page":"CD004193","article-title":"Anticholinergics for urinary symptoms in multiple sclerosis","volume":"1","author":"Nicholas","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.rehab.2014.05.004_bib0040","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1179\/2045772313Y.0000000116","article-title":"Use of botulinum toxin in individuals with neurogenic detrusor overactivity: state of the art review","volume":"36","author":"Linsenmeyer","year":"2013","journal-title":"J Spinal Cord Med"},{"key":"10.1016\/j.rehab.2014.05.004_bib0045","first-page":"734","article-title":"Botulinum toxin injection of eye muscles to correct strabismus","volume":"79","author":"Scott","year":"1981","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.rehab.2014.05.004_bib0050","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.toxicon.2008.12.012","article-title":"Different mechanisms of inhibition of nerve terminals by botulinum and snake presynaptic neurotoxins","volume":"54","author":"Montecucco","year":"2009","journal-title":"Toxicon"},{"key":"10.1016\/j.rehab.2014.05.004_bib0055","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1152\/physrev.2000.80.2.717","article-title":"Neurotoxins affecting neuroexocytosis","volume":"80","author":"Schiavo","year":"2000","journal-title":"Physiol Rev"},{"key":"10.1016\/j.rehab.2014.05.004_bib0060","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.eururo.2005.12.010","article-title":"Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity","volume":"49","author":"Apostolidis","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.rehab.2014.05.004_bib0065","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/00365590601068835","article-title":"Efficay and impact of botulinum toxin A on quality of life in patients with neurogenic detrusor overactivity: a randomised, placebo-controlled, double-blind study","volume":"41","author":"Ehren","year":"2007","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.rehab.2014.05.004_bib0070","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.eururo.2007.09.034","article-title":"Neurogenic detrusor overactivity treated with English botulinum toxin A: 8-year experience of one single centre","volume":"53","author":"Del Popolo","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.rehab.2014.05.004_bib0075","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.eururo.2004.11.009","article-title":"Success of repeat detrusor injections of botulinum A toxin in patients with severe neurogenic detrusor overactivity and incontinence","volume":"47","author":"Grosse","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.rehab.2014.05.004_bib0080","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0003-9993(03)00202-8","article-title":"Use of botulinum toxin type B for the treatment of detrusor hyperreflexia in a patient with multiple sclerosis: a case report","volume":"84","author":"Dykstra","year":"2003","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.rehab.2014.05.004_bib0085","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1097\/01.ju.0000177477.83991.88","article-title":"Effects of botulinum toxin B on refractory detrusor overactivity: a randomized, double-blind, placebo-controlled, crossover trial","volume":"174","author":"Ghei","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.rehab.2014.05.004_bib0090","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.urology.2006.09.005","article-title":"Botulinum toxin B is not an effective treatment of refractory overactive bladder","volume":"69","author":"Hirst","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.rehab.2014.05.004_bib0095","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/01.ju.0000162035.73977.1c","article-title":"Botulinum toxin type A is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo-controlled 6-month study","volume":"174","author":"Schurch","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.rehab.2014.05.004_bib0100","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.eururo.2003.12.004","article-title":"European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity","volume":"45","author":"Reitz","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.rehab.2014.05.004_bib0105","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/nau.20153","article-title":"Efficacy of botulinum-A toxin bladder injections for the treatment of neurogenic detrusor overactivity in multiple sclerosis patients: an objective and subjective analysis","volume":"25","author":"Schulte-Baukloh","year":"2006","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.rehab.2014.05.004_bib0110","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/ana.21209","article-title":"Botulinum injections for the treatment of bladder symptoms of multiple sclerosis","volume":"62","author":"Kalsi","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1016\/j.rehab.2014.05.004_bib0115","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.eururo.2007.08.039","article-title":"Botulinum toxin A detrusor injections in patients with neurogenic detrusor overactivity significantly decrease the incidence of symptomatic urinary tract infections","volume":"53","author":"Game","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.rehab.2014.05.004_bib0120","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1590\/S1677-55382011000500012","article-title":"Botulinum toxin A for the treatment of neurogenic detrusor overactivity in multiple sclerosis patients","volume":"37","author":"Deffontaines-Rufin","year":"2011","journal-title":"Int Braz J Urol"},{"key":"10.1016\/j.rehab.2014.05.004_bib0125","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1016\/j.juro.2011.02.004","article-title":"Efficacy of botulinum toxin A injection for neurogenic detrusor overactivity and urinary incontinence: a randomized, double-blind trial","volume":"185","author":"Herschorn","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.rehab.2014.05.004_bib0130","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.eururo.2011.07.002","article-title":"Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial","volume":"60","author":"Cruz","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.rehab.2014.05.004_bib0135","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1016\/j.juro.2012.01.125","article-title":"Phase\u00a03 efficacy and tolerability study of onabotulinumtoxinA for urinary incontinence from neurogenic detrusor overactivity","volume":"187","author":"Ginsberg","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.rehab.2014.05.004_bib0140","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.purol.2012.10.006","article-title":"Five years follow-up study and failures analysis of botulinum toxin repeated injections to treat neurogenic detrusor overactivity","volume":"22","author":"Gaillet","year":"2012","journal-title":"Prog Urol"},{"key":"10.1016\/j.rehab.2014.05.004_bib0145","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.eururo.2007.08.052","article-title":"Do repeat intradetrusor botulinum toxin type A injections yield valuable results? Clinical and urodynamic results after five injections in patients with neurogenic detrusor overactivity","volume":"52","author":"Reitz","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.rehab.2014.05.004_bib0150","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.eururo.2007.04.026","article-title":"Botulinum toxin\u00a0A improves the quality of life in patients with neurogenic urinary incontinence","volume":"52","author":"Schurch","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.rehab.2014.05.004_bib0155","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.eururo.2005.11.006","article-title":"Cost-consequence analysis evaluating the dose of botulinum neurotoxin-A in patients with detrusor overactivity based on clinical outcomes observed at a single UK centre","volume":"49","author":"Kalsi","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.rehab.2014.05.004_bib0160","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.juro.2010.12.002","article-title":"Long-term effect on quality of life of repeat detrusor injections of botulinum neurotoxin-A for detrusor overactivity in patients with multiple sclerosis","volume":"185","author":"Khan","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.rehab.2014.05.004_bib0165","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1136\/jnnp.2004.045765","article-title":"Placebo-controlled, randomised, double-blind study of the effects of botulinum A toxin on detrusor-sphincter dyssynergia in multiple sclerosis patients","volume":"76","author":"Gallien","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.rehab.2014.05.004_bib0170","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/nau.21003","article-title":"Epidemiology and healthcare utilization of neurogenic bladder patients in a US claims database","volume":"30","author":"Manack","year":"2011","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.rehab.2014.05.004_bib0175","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/j.1464-410X.2011.10216.x","article-title":"Risk of urinary tract infection after detrusor botulinum toxin A injections for refractory neurogenic detrusor overactivity in patients with no antibiotic treatment","volume":"107","author":"Harris","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.rehab.2014.05.004_bib0180","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1111\/j.1464-410X.2010.09435.x","article-title":"Risk of urinary tract infection after detrusor botulinum toxin A injections for refractory neurogenic detrusor overactivity in patients with no antibiotic treatment","volume":"106","author":"Mouttalib","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.rehab.2014.05.004_bib0185","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.juro.2010.05.035","article-title":"The effect of botulinum toxin type A on overactive bladder symptoms in patients with multiple sclerosis: a pilot study","volume":"184","author":"Mehnert","year":"2010","journal-title":"J Urol"}],"container-title":["Annals of Physical and Rehabilitation Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877065714017230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877065714017230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,10]],"date-time":"2018-12-10T16:05:52Z","timestamp":1544457952000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877065714017230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S1877065714017230"],"URL":"https:\/\/doi.org\/10.1016\/j.rehab.2014.05.004","relation":{},"ISSN":["1877-0657"],"issn-type":[{"value":"1877-0657","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"OnabotulinumtoxinA and multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Annals of Physical and Rehabilitation Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rehab.2014.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}